ETROLIZUMAB VERSUS PLACEBO IN TUMOR NECROSIS FACTOR ANTAGONIST NAIVE PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE RANDOMIZED PHASE 3 LAUREL TRIAL

Severine Vermeire  ¹     Peter L Lakatos  ²     Timothy Ritter  ³     Stephen B Hanauer  ⁴     Brian Bressler  ⁵     Reena Khanna  ⁶     Kim Isaacs  ⁷     Saumin Shah  ⁸     Alysha Khavarian Kadva     Helen Tyrrell     Young Oh     Swati Tole     Akiko Chai     Jennifer Pulley     Wenhui Zhang     Brian G. Feagan    
¹ University Hospital Leuven,Leuven,Belgium
² McGill University,Montreal,Canada
³ GI Alliance,Southlake,United States
⁴ Northwestern University,Chicago,United States
⁵ St. Paul’s Hospital,Vancouver,Canada
⁶ Western University,London,Canada
⁷ University of North Carolina School of Medicine,Chapel Hill,United States
⁸ Gujarat Hospital, Gastro

Session
Late breaking abstracts: GI inflammation and infection - From IBD to eosinophilic oesophagitis

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)